(Public Relations Pacific LLC) NeuroVision Imaging LLC ('NeuroVision') today announced its participation in a new substudy with investigators at the University of California San Diego School of Medicine (UC San Diego) and the University of Southern California (USC) to be part of the landmark Anti-Amyloid Treatment in Asymptomatic Alzheimer's (or 'A4') clinical trial. The purpose of the A4 study is to test whether a new investigational treatment that may reduce beta-amyloid accumulation in the brain can also slow memory loss caused by Alzheimer's disease.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2mpxLOO
No comments:
Post a Comment